Crossmark

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party

Crossref DOI link: https://doi.org/10.1038/bmt.2015.286

Published Online: 2015-11-30

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Robinson, S P

Boumendil, A

Finel, H

Blaise, D

Poiré, X

Nicolas-Virelizier, E

Or, R

Malladi, R

Corby, A

Fornecker, L

Caballero, D

Pohlreich, D

Nagler, A

Thieblemont, C

Finke, J

Bachy, E https://orcid.org/0000-0003-2694-7510
Vincent, L https://orcid.org/0000-0001-5904-1286
Schroyens, W

Schouten, H

Dreger, P
License Information

Text and Data Mining valid from 2015-11-30

Version of Record valid from 2015-11-30
More Information

Article History

Received: 26 May 2015

Revised: 6 September 2015

Accepted: 19 September 2015

First Online: 30 November 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below